12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. Inspire Veterinary (IVP) saw a 178.9% increase, Aclarion (ACON) rose by 115.01%, and Panbela Therapeutics (PBLA) went up by 61.23%. Conversely, Onconetix (ONCO) dropped by 32.8%, Jin Medical International (ZJYL) fell by 18.52%, and Passage Bio (PASG) declined by 11.09%. Other notable movements included gains for Corbus Pharmaceuticals (CRBP), NeuBase Therapeutics (NBSE), and Ainos (AIMD), and losses for PTC Therapeutics (PTCT), Aravive (ARAV), and Sagimet Biosciences (SGMT).
January 26, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Onconetix's stock decreased by 32.8% to $0.23, with outstanding shares valued at $5.0 million.
The significant pre-market drop for ONCO could reflect negative news or investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Passage Bio's shares declined by 11.09% to $0.81, with a market value of $44.4 million.
The pre-market decline in PASG's stock price suggests negative investor sentiment, which could continue to pressure the stock in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Jin Medical International's stock fell by 18.52% to $224.99, with a market value of $1.7 billion.
The drop in ZJYL's stock price could indicate market concerns, potentially leading to further short-term declines.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Aclarion's stock increased by 115.01% to $4.01, with a market cap of $3.3 million.
Aclarion's significant pre-market rise could attract more attention, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Inspire Veterinary's stock soared by 178.9% to $0.52, with a market cap of $5.7 million.
The substantial pre-market gain for IVP indicates strong investor interest, which could lead to continued short-term upward price momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Panbela Therapeutics' stock increased by 61.23% to $5.24, with outstanding shares valued at $2.5 million.
The sharp increase in PBLA's stock price suggests positive investor sentiment, which could lead to further short-term price appreciation.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100